Stocktoria

TREACE MEDICAL CONCEPTS, INC. TMCI

Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-04-23
Chart by TradingView
2/9
Piotroski F — financial health
-1.79
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$212.7M$209.4M$187.1M$141.8M$94.4M
Gross profit$169.8M$168.3M$151.9M$116.3M$77.5M
Operating income-$54.2M-$55.7M-$51.4M-$34.8M-$16.5M
Net income-$59.0M-$55.7M-$49.5M-$42.8M-$20.6M
Operating cash flow-$16.0M-$37.2M-$34.6M-$30.6M-$17.2M
Free cash flow-$29.5M-$48.8M-$46.0M-$45.5M-$19.9M
Total assets$190.6M$217.1M$251.9M$159.0M$140.8M
Total liabilities$103.2M$104.2M$114.0M$98.5M$47.7M
Shareholders' equity$87.3M$112.9M$137.9M$60.5M$93.1M
Ratios
Gross margin79.8%80.4%81.2%82.0%82.1%
Operating margin-25.5%-26.6%-27.5%-24.6%-17.5%
Net margin-27.7%-26.6%-26.5%-30.2%-21.8%
FCF margin-13.9%-23.3%-24.6%-32.1%-21.1%
Return on assets-31.0%-25.7%-19.7%-26.9%-14.6%
Return on equity-67.6%-49.4%-35.9%-70.7%-22.1%
Debt / equity0.64×0.47×0.38×0.87×0.32×
Current ratio4.314.624.404.417.58
Revenue growth1.6%11.9%31.9%50.2%64.6%

Notable holders (13F)

InvestorSharesValue
RENAISSANCE TECHNOLOGIES LLC522,900$700,686

Why these scores methodology →

Piotroski F-score: 2/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: -1.79 (distress)

  • Working capital / assets 0.532
  • Retained earnings / assets -1.306
  • EBIT / assets -0.284
  • Equity / liabilities 0.846

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001630627 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.